![Mette Thorn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mette Thorn worked as a Senior Vice President-Preclinical Development at Expres2ion Biotech Holding AB from 2021 to 2023.
She received a graduate and doctorate degree from the Technical University of Denmark.
Anciens postes connus de Mette Thorn
| Sociétés | Poste | Fin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur Technique/Scientifique/R&D | 29/09/2023 |
Formation de Mette Thorn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
